RBC Capital Analyst Reiterates Outperform Rating for Sophia Genetics
RBC Capital analyst Conor McNamara has once again backed Sophia Genetics (NASDAQ:SOPH) with an Outperform rating, setting a price target ...
Tag: SOPH
RBC Capital Analyst Reiterates Outperform Rating and Sets 8 Price Target for SOPHiA Genetics
On January 12, 2024, Conor McNamara, an analyst at RBC Capital, expressed his optimistic view on Sophia Genetics (NASDAQ:SOPH) by ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
NextGen Healthcare Charts Course for Behavioral Health Transformation
-
Regulatory Shift Sparks Potential Breakthrough for DeFi Technologies
